Granix
Manufacturing · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
400 Interpace Pkwy, Parsippany, New Jers...Website
www.granixrx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Granix
Teva Pharmaceuticals, Inc. offers GRANIX, a prescription medication designed to treat severe neutropenia in adults and children over one month old undergoing chemotherapy for certain types of cancer. The product aims to reduce the duration of low neutrophil counts, which are critical for fighting infections. Teva targets healthcare professionals and patients affected by cancer treatments, providing resources and information to support their needs. The company emphasizes safety and potential side effects associated with GRANIX, ensuring informed usage among its clients.Explore more
Popular SearchesGranixSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Granix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Granix, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Granix launches new products
Congratulate Masked Content for being promoted to Masked Content at Granix
Funding: Get notified immidiatlly once Granix has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Granix had a recent Job posting/layoffs
Earning: See what the market has to say on Granix recently announced quarterly report
Check out if Granix is spiking on competitors!
Check if Granix has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Granix
Find 2 more new buyers
Compare Similar Companies to Granix
Compare insights from companies similar to Granix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Granix
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Granix is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Granix is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Granix.
Granix Tech Stack
A closer look at the technologies used by Granix
Granix News & Media
Teva Announces Updated Indication and Vial Presentation for GRANIX® (tbo-filgrastim) Injection in United States
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved GRANIX® (tbo-filgrastim) Injection for a new vial presentation and indication in pediatric patients 1 month and older. GRANIX is indicated to reduce the duration of severe neutropenia in adult and pediatric patients 1 month and older with nonmyeloid malignancies receiving myelosuppressive anticancer drugs associated with a clinicallyTeva Announces Updated Indication and Vial Presentation for GRANIX® (tbo-filgrastim) Injection in United States
JERUSALEM--(BUSINESS WIRE)--Aug. 6, 2018-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved GRANIX® (tbo-filgrastim) Injection for a new vial presentation and indication in pediatric patients 1 month and older. GRANIX is indicated to reduce the duration of severe neutropenia in adult and pediatric patients 1 month and older with nonmyeloid malignancies receiving myelosuppressive anticancer drugs associated wit
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Granix
Sign Up For FreeTo access detailed company insights
Teva Pharmaceuticals, Inc. offers GRANIX, a prescription medication designed to treat severe neutropenia in adults and children over one month old undergoing chemotherapy for certain types of cancer. The product aims to reduce the duration of low neutrophil counts, which are critical for fighting infections. Teva targets healthcare professionals an... Read More
